<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286465</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-17-0280</org_study_id>
    <nct_id>NCT03286465</nct_id>
  </id_info>
  <brief_title>Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions</brief_title>
  <official_title>Pilot, Randomized Trial of the Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the hypothesis that the use of pediatric size phlebotomy tubes
      reduces RBC transfusions in adult ICU patients compared with the use of adult size tubes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from randomization to hemoglobin less than 7 g/dL or red blood cell (RBC) transfusion order</measure>
    <time_frame>anywhere from admission to intensive care unit (ICU) up until 30 days after admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of change in hemoglobin (g/dL/patient/day) in the intensive care unit (ICU)</measure>
    <time_frame>baseline, completion of study (up to 30 days after ICU admission)</time_frame>
    <description>This will be calculated as the most recent hemoglobin prior to randomization minus the last hemoglobin prior to ICU discharge, death, RBC transfusion, clinical bleeding, surgery, or change of clinical status to comfort measures, divided by the number of days (rounded to the nearest 0.5) between these two values (crude estimate).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants receiving an RBC transfusion while in the ICU</measure>
    <time_frame>completion of study (up to 30 days after ICU admission)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with at least one inadequate blood sample for laboratory analysis</measure>
    <time_frame>completion of study (up to 30 days after ICU admission)</time_frame>
    <description>An inadequate blood sample is defined as any blood sample that requires recollection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>completion of study (up to 30 days after ICU admission)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total daily phlebotomy volume</measure>
    <time_frame>completion of study (up to 30 days after ICU admission)</time_frame>
    <description>The total daily phlebotomy volume per participant will be calculated based on the number of blood tests per patient per day and the minimal blood volume for analysis of each test.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Pediatric phlebotomy tubes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of pediatric size tubes for diagnostic blood collection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult phlebotomy tubes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of adult size tubes for diagnostic blood collection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pediatric phlebotomy tubes</intervention_name>
    <description>Use of pediatric size tubes for diagnostic blood collection.</description>
    <arm_group_label>Pediatric phlebotomy tubes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adult phlebotomy tubes</intervention_name>
    <description>Use of adult size tubes for diagnostic blood collection.</description>
    <arm_group_label>Adult phlebotomy tubes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New admission to the medical or transplant ICU at Memorial Hermann Hospital in Houston

          -  ICU admission hemoglobin level of at least 7 g/dL. The ICU admission hemoglobin will
             be the most recent hemoglobin value available at the time of screening for inclusion
             in the study.

          -  Randomization is expected within 12 hour of admission to the ICU

        Exclusion Criteria:

          -  Clinical bleeding. Defined as menstrual bleeding, bleeding leading to a change in the
             frequency of hemoglobin monitoring or to an order for a medication, transfusion,
             procedure, or consultation intended to prevent or treat bleeding.

          -  Known hemolytic disorder (e.g. sickle cell disease, hereditary spherocytosis,
             autoimmune hemolytic anemia)

          -  Bone marrow disorder (e.g. aplastic anemia, marrow infiltration disorder, chemotherapy
             within the last 8 weeks)

          -  Jehovah's Witnesses

          -  Patient is comfort care measures only

          -  Refractory shock: mean arterial blood pressure below 60 mmHg despite maximal doses of
             3 vasopressors. Maximal dose of vasopressors are as follows: Norepinephrine 70
             mcg/min; vasopressin 0.04 units/min; epinephrine 35 mcg/min; dopamine 20 mcg/kg/min;
             phenylephrine 350 mcg/min

          -  Severe acidosis: pH below 7 in more than one arterial blood gas within 24 hours of ICU
             admission in the absence of diabetic ketoacidosis Surgical admission diagnosis

          -  Pregnancy

          -  Current prisoner
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier Barreda Garcia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Javier Barreda Garcia, MD</last_name>
    <phone>713-500-6828</phone>
    <email>Javier.BarredaGarcia@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Barreda Garcia, MD</last_name>
      <phone>713-500-6828</phone>
      <email>Javier.BarredaGarcia@uth.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Javier Barreda Garcia</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>blood transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

